Paper38672011
The Effect of Antipsychotics on Cognition in Schizophrenia-A Current Narrative Review.
Lungu PF and 8 others. Brain Sci, 2024. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Effect of Antipsychotics on Cognition in Schizophrenia-A Current Narrative Review. Papers, record 38672011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38672011
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References111
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7,559,378 | Antipsychotic effect of cannabidiol. | J Clin Psychiatry | 1995 | https://conductscience.org/library/papers/7559378 | PubMed |
| 2 | 32,141,723 | Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study. | J Clin Psychiatry | 2020 | https://conductscience.org/library/papers/32141723 | PubMed |
| 3 | 9,090,333 | Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance. | Am J Psychiatry | 1997 | https://conductscience.org/library/papers/9090333 | PubMed |
| 4 | 16,793,238 | Antipsychotic medication and cognitive function in schizophrenia. | Schizophr Res | 2006 | https://conductscience.org/library/papers/16793238 | PubMed |
| 5 | 15,784,157 | A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. | Int J Neuropsychopharmacol | 2005 | https://conductscience.org/library/papers/15784157 | PubMed |
| 6 | 2,602,512 | The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia. | Psychopharmacol Bull | 1989 | https://conductscience.org/library/papers/2602512 | PubMed |
| 7 | 17,548,746 | Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. | Arch Gen Psychiatry | 2007 | https://conductscience.org/library/papers/17548746 | PubMed |
| 8 | 29,413,518 | Unique Effects of Clozapine: A Pharmacological Perspective. | Adv Pharmacol | 2018 | https://conductscience.org/library/papers/29413518 | PubMed |
| 9 | 10,416,729 | The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. | Schizophr Bull | 1999 | https://conductscience.org/library/papers/10416729 | PubMed |
| 10 | 27,267,317 | Could cannabidiol be used as an alternative to antipsychotics? | J Psychiatr Res | 2016 | https://conductscience.org/library/papers/27267317 | PubMed |
| 11 | 15,205,874 | Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. | Psychopharmacology (Berl) | 2004 | https://conductscience.org/library/papers/15205874 | PubMed |
| 12 | 22,795,368 | Antipsychotics, dopamine D₂ receptor occupancy and clinical improvement in schizophrenia: a meta-analysis. | Schizophr Res | 2012 | https://conductscience.org/library/papers/22795368 | PubMed |
| 13 | 17,163,083 | Screening for dementia in community-based memory clinics. | WMJ | 2006 | https://conductscience.org/library/papers/17163083 | PubMed |
| 14 | 7,323,768 | The epidemiology of paranoid schizophrenia. | Schizophr Bull | 1981 | https://conductscience.org/library/papers/7323768 | PubMed |
| 15 | 14,702,259 | Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. | Am J Psychiatry | 2004 | https://conductscience.org/library/papers/14702259 | PubMed |
| 16 | 11,470,207 | Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients. | J Pharm Biomed Anal | 2001 | https://conductscience.org/library/papers/11470207 | PubMed |
| 17 | 22,193,671 | The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. | Am J Psychiatry | 2011 | https://conductscience.org/library/papers/22193671 | PubMed |
| 18 | 24,145,817 | Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis. | Eur J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/24145817 | PubMed |
| 19 | 18,801,821 | Cannabidiol for the treatment of psychosis in Parkinson's disease. | J Psychopharmacol | 2009 | https://conductscience.org/library/papers/18801821 | PubMed |
| 20 | 24,648,768 | Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper. | Drug Healthc Patient Saf | 2014 | https://conductscience.org/library/papers/24648768 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,530,321 | Reduced categorical congruence of cognitive and affective empathy in persons with psychotic disorders. | Sci Rep | 2026 | https://conductscience.org/library/papers/41530321 | PubMed |
| 41,211,592 | Comparison of ziprasidone and olanzapine on cognitive function in patients with schizophrenia at different stages: a prospective study in Huai'an, China. | Front Behav Neurosci | 2025 | https://conductscience.org/library/papers/41211592 | PubMed |
| 41,155,663 | Preliminary Data Regarding the Alleviating Effects of Haloperidol and Risperidone on the Short-Term Memory and Associative Learning in a Zebrafish Model of Schizophrenia. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155663 | PubMed |
| 40,859,289 | Cognitive impairment and its influencing factors in patients with stable schizophrenia on regular medication: a real-world clinical study. | BMC Psychiatry | 2025 | https://conductscience.org/library/papers/40859289 | PubMed |
| 40,830,229 | Neurobehavioral profile of individuals with pathogenic variants in CHD3. | Eur J Hum Genet | 2025 | https://conductscience.org/library/papers/40830229 | PubMed |
| 40,817,421 | Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database. | Int J Geriatr Psychiatry | 2025 | https://conductscience.org/library/papers/40817421 | PubMed |
| 38,891,871 | D3 Receptor-Targeted Cariprazine: Insights from Lab to Bedside. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38891871 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38672011
GET https://conductscience.org/api/papers/v1/38672011/references?page=2